Deligne SRL
2.6 FTEDeligne reported total assets of €2.71m at the end of the 2025 financial year (annual accounts filed with the NBB on 02 Jun 2026), with 2.6 full-time equivalents.
The score of Deligne shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -10 % Total assets -8 % Headcount (avg FTE) 0 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Deligne's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 02 Jun 2026
- Year ended 31 Dec 2024filed on 30 May 2025
- Year ended 31 Dec 2023filed on 07 Jun 2024
- Year ended 31 Dec 2022filed on 16 Jun 2023
- Year ended 31 Dec 2021filed on 01 Jul 2022
Deligne's financial analysis
- Solvency46.9%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Deligne
Deligne's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0476.126.874
- VAT number
- BE0476126874
- Peppol
- Registered · 0208:0476126874 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 22 Nov 2001
- Registered office
- 7812 Ath
- Size
- Micro · 2.6 FTE
- Latest accounts
- 2025 · filed on 02 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Deligne (SRL) has been based in Ath since 2001, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 156,365 € and equity of €1.27m; its revenue is not published. With 2.6 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 46.9%, above the median of its sector (41.5%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Deligne
Companies in the same business, of comparable size and area, outside its group.
- Elbaro Retail sale of pharmaceutical products Merelbeke-Melle · balance sheet €2.78m
- Philippe Sollie Retail sale of pharmaceutical products Zoersel · balance sheet €2.69m
- Pharmacie Forthomme Retail sale of pharmaceutical products Bastogne · balance sheet €2.74m
- Apotheek Delbeke - Aerts Retail sale of pharmaceutical products Hooglede · balance sheet €2.74m
- "Westland Pharma" Retail sale of pharmaceutical products Anderlecht · balance sheet €2.76m
- Ollo Pharma Retail sale of pharmaceutical products Marche-en-Famenne · balance sheet €2.66m
- Delfosse Marie Retail sale of pharmaceutical products Tournai · balance sheet €2.65m
- Pharmalaw Retail sale of pharmaceutical products Anderlecht · balance sheet €2.78m
Frequently asked questions about Deligne
What is the revenue of Deligne?
Deligne files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Deligne?
In Belgium, the VAT number is the company number prefixed with BE: BE0476126874 for Deligne, if the company is VAT-registered. Its company number (CBE) is 0476.126.874.
Where is the registered office of Deligne?
According to the CBE register, the registered office of Deligne is in 7812 Ath.
What is the equity of Deligne?
At the close of the 2025 financial year, the equity of Deligne amounts to 1,272,793 €, a solvency of 46.9% of total assets.
How many people work at Deligne?
2.6 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Deligne?
The register lists 1 active mandates at Deligne. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Deligne
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →